Letrozole and desogestrel‐only contraceptive pill for the treatment of stage IV endometriosis
- 5 June 2007
- journal article
- clinical trial
- Published by Wiley in Australian and New Zealand Journal of Obstetrics and Gynaecology
- Vol. 47 (3) , 222-225
Abstract
Background: It has recently been suggested that aromatase inhibitors may effectively reduce pain symptoms related to the presence of endometriosis both in postmenopausal women and in subjects of reproductive age.Aims: This study aims to evaluate the effectiveness of a combination of letrozole and desogestrel in the treatment of pain symptoms related to the presence of endometriosis.Methods: This open‐label prospective study included 12 women with endometriosis‐related pain symptoms that were refractory to previous medical and surgical treatments. All women had previous laparoscopy documenting stage IV endometriosis. The treatment protocol included the daily oral administration of letrozole 2.5 mg (Femara®), desogestrel 75 µg (Cerazette®), elemental calcium 1000 mg and vitamin D 880 I.U. The scheduled treatment period was six months.Results: None of the women included in the study completed the six‐month treatment because all patients developed ovarian cysts; the median length of treatment was 84 days (range, 56–112). At interruption of treatment, all women reported significant improvements in dysmenorrhoea and dyspareunia. Pain symptoms quickly recurred at three‐month follow up. There were no severe adverse effects of treatment; no significant change in the mineral bone density was observed during treatment.Conclusions: The combination of letrozole and desogestrel induces a relief of pain symptoms in women with endometriosis but it causes the development of ovarian cysts. Pain symptoms quickly recur after the completion of treatment.Keywords
This publication has 13 references indexed in Scilit:
- Future Perspectives in the Medical Treatment of EndometriosisObstetrical & Gynecological Survey, 2005
- Anastrazole and oral contraceptives: a novel treatment for endometriosisFertility and Sterility, 2005
- Successful treatment of severe endometriosis in two premenopausal women with an aromatase inhibitorFertility and Sterility, 2004
- Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot studyFertility and Sterility, 2004
- Treatment of severe recurrent endometriosis with an aromatase inhibitor in a young ovariectomised womanBJOG: An International Journal of Obstetrics & Gynaecology, 2004
- A comparison of the inhibition of ovulation achieved by desogestrel 75 g and levonorgestrel 30 g dailyHuman Reproduction, 1999
- Treatment of Severe Postmenopausal Endometriosis With an Aromatase InhibitorFertility and Sterility, 1998
- Aromatase expression in endometriosisThe Journal of Clinical Endocrinology & Metabolism, 1996
- Selectivity information on desogestrelAmerican Journal of Obstetrics and Gynecology, 1993
- Revised American Fertility Society Classification of Endometriosis: 1985Fertility and Sterility, 1985